ASX - By Stock
|
EYE |
Re:
Ann: Proposed USA Medicare Changes
|
|
HoracioL
|
51 |
10K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
51
|
10K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
2023 Charts
|
|
HoracioL
|
2.0K |
760K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
2.0K
|
760K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
AGY Shorts
|
|
HoracioL
|
1.0K |
292K |
6 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
1.0K
|
292K
|
6
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
HoracioL
|
8 |
2.6K |
0 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
Ann: Rincon Test Pumping Results
|
|
HoracioL
|
42 |
21K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
42
|
21K
|
4
|
|
ASX - By Stock
|
AGY |
Re:
AGY Shorts
|
|
HoracioL
|
1.0K |
292K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
292K
|
4
|
|
ASX - By Stock
|
AML |
Re:
Ann: Substantial Growth in Walford Creek Mineral Resources
|
|
HoracioL
|
24 |
17K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
24
|
17K
|
1
|
|
ASX - By Stock
|
AML |
Re:
Ann: Substantial Growth in Walford Creek Mineral Resources
|
|
HoracioL
|
24 |
17K |
0 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
24
|
17K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
AGY Shorts
|
|
HoracioL
|
1.0K |
292K |
3 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
1.0K
|
292K
|
3
|
|
ASX - By Stock
|
TGH |
Re:
Ann: MYLO supplement shown to improve milk yield by 10%
|
|
HoracioL
|
7 |
4.1K |
0 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
7
|
4.1K
|
0
|
|
ASX - By Stock
|
AML |
Re:
Ann: Substantial Growth in Walford Creek Mineral Resources
|
|
HoracioL
|
24 |
17K |
3 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
24
|
17K
|
3
|
|
ASX - By Stock
|
TGH |
Re:
Ann: MYLO supplement shown to improve milk yield by 10%
|
|
HoracioL
|
7 |
4.1K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
7
|
4.1K
|
0
|
|
ASX - By Stock
|
TGH |
Re:
Ann: MYLO supplement shown to improve milk yield by 10%
|
|
HoracioL
|
7 |
4.1K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
7
|
4.1K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
AGY Shorts
|
|
HoracioL
|
1.0K |
292K |
3 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
1.0K
|
292K
|
3
|
|
ASX - By Stock
|
LGP |
Re:
2023 for LGP
|
|
HoracioL
|
30 |
21K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
30
|
21K
|
0
|
|
ASX - By Stock
|
LGP |
Re:
2023 for LGP
|
|
HoracioL
|
30 |
21K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
30
|
21K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
HoracioL
|
2.7K |
666K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
2.7K
|
666K
|
0
|
|
ASX - By Stock
|
AGY |
Re:
General Discussion AGY
|
|
HoracioL
|
22K |
7.4M |
1 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
22K
|
7.4M
|
1
|
|
ASX - By Stock
|
JRV |
Re:
Ann: Jervois suspends final construction at ICO
|
|
HoracioL
|
285 |
118K |
1 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
285
|
118K
|
1
|
|
ASX - By Stock
|
JRV |
Re:
Ann: Jervois suspends final construction at ICO
|
|
HoracioL
|
285 |
118K |
1 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
285
|
118K
|
1
|
|
ASX - By Stock
|
JRV |
Re:
Ann: Jervois suspends final construction at ICO
|
|
HoracioL
|
285 |
118K |
1 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
285
|
118K
|
1
|
|
ASX - By Stock
|
JRV |
Re:
Ann: Jervois suspends final construction at ICO
|
|
HoracioL
|
285 |
118K |
11 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
285
|
118K
|
11
|
|
ASX - By Stock
|
NTO |
Re:
Ann: Improved Potentia Takeover Offer
|
|
HoracioL
|
7 |
4.2K |
0 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
7
|
4.2K
|
0
|
|
ASX - By Stock
|
NTO |
Re:
Ann: Potentia's Relevant Interest Exceeds 50%
|
|
HoracioL
|
6 |
4.0K |
0 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
6
|
4.0K
|
0
|
|
ASX - By Stock
|
TGH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoracioL
|
6 |
2.7K |
1 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
6
|
2.7K
|
1
|
|
ASX - By Stock
|
NTO |
Re:
Ann: Improved Potentia Takeover Offer
|
|
HoracioL
|
7 |
4.2K |
1 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
7
|
4.2K
|
1
|
|
ASX - By Stock
|
NTO |
Re:
Ann: Improved Potentia Takeover Offer
|
|
HoracioL
|
7 |
4.2K |
2 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
7
|
4.2K
|
2
|
|